The cost of hepatitis C and the cost–effectiveness of its prevention
- 30 November 2001
- journal article
- Published by Elsevier in Health Policy
- Vol. 58 (2) , 121-131
- https://doi.org/10.1016/s0168-8510(01)00159-2
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Modelling the hepatitis C virus epidemic in AustraliaJournal of Gastroenterology and Hepatology, 1999
- Evaluating the Burden of Disease and Spending the Research Dollars of the National Institutes of HealthNew England Journal of Medicine, 1999
- Determinants of outcome of compensated hepatitis C virus-related cirrhosisHepatology, 1998
- National Institutes of Health Consensus Development Conference Panel statement: Management of hepatitis CHepatology, 1997
- Methadone maintenance and hepatitis C virus infection among injecting drug usersAddiction, 1997
- Methadone Maintenance and the Likelihood of Risky Needle-SharingInternational Journal of the Addictions, 1995
- Cost of illness studies: no aid to decision making? Comments on the Second Opinion by Shiell et al. (Health Policy, 8 (1987) 317–323)Health Policy, 1989
- Cost of illness studies: An aid to decision-making?Health Policy, 1987
- The economic cost of illness in the Federal Republic of Germany in the year 1980Health Policy, 1986
- Measuring Benefits In Health: A ClarificationScottish Journal of Political Economy, 1981